PHARMAFORCE Trademark

Trademark Overview

On Tuesday, March 20, 2018, a trademark application was filed for PHARMAFORCE with the United States Patent and Trademark Office. The USPTO has given the PHARMAFORCE trademark a serial number of 87841944. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 7, 2019. This trademark is owned by Luitpold Pharmaceuticals, Inc.. The PHARMAFORCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations, namely, anabolic steroids, steroids, anticonvulsants, antidotes for ethylene glycol and methanol poisoning, bone resorption inhibitors, narcotic analgesics, respiratory stimulants, oxytocics, diuretics, antipsychotics, cholinesterase inhibitors, antivirals, antineoplastics, antispasmodics, anticholinergics, muscle relaxants, estrogens, progestins, hydroxyprogesterone caproate, and medroxyprogesterone; Pharmaceuticals and pharmaceutical preparations for the treatment of rheumatic disorders, renal and neoplastic diseases, amenorrhea and abnormal uterine bleeding, severe pain, anemia, hypocalcemia and lymphatic disorders
pharmaforce

General Information

Serial Number87841944
Word MarkPHARMAFORCE
Filing DateTuesday, March 20, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations, namely, anabolic steroids, steroids, anticonvulsants, antidotes for ethylene glycol and methanol poisoning, bone resorption inhibitors, narcotic analgesics, respiratory stimulants, oxytocics, diuretics, antipsychotics, cholinesterase inhibitors, antivirals, antineoplastics, antispasmodics, anticholinergics, muscle relaxants, estrogens, progestins, hydroxyprogesterone caproate, and medroxyprogesterone; Pharmaceuticals and pharmaceutical preparations for the treatment of rheumatic disorders, renal and neoplastic diseases, amenorrhea and abnormal uterine bleeding, severe pain, anemia, hypocalcemia and lymphatic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLuitpold Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShirley, NY 11967

Trademark Events

Event DateEvent Description
Friday, February 8, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 7, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, June 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 21, 2018NON-FINAL ACTION E-MAILED
Thursday, June 21, 2018NON-FINAL ACTION WRITTEN
Monday, June 18, 2018ASSIGNED TO EXAMINER
Thursday, March 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 23, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaforce steroids pharmaceuticals inhibitors disorders preparations pharmaceutical treatment rheumatic medroxyprogesterone progestins